Disclosure: The Iron Verdict may earn commissions from qualifying purchases at no extra cost to you. Learn more ->

“Ozempic Face”: What The Review Actually Found

Everyone writing about this treats the drug as the cause. The systematic review that looked at the evidence reached a different conclusion, and it changes what you should do about it.

Publication date: 2026-08-09Last updated: 2026-08-09Reading time: 6 minAuthor: The Iron Verdict Research Team

What You'll Learn

What ChangesThe specific areas affected.
The FindingWhat the review concluded about cause.
Why It HappensFacial fat, and why it is not special.
Age MattersWhy it looks worse at 55 than at 30.
Can You Prevent ItWhat is and is not in your control.
PerspectiveThe trade-off nobody frames properly.

Table of Contents

  1. What Actually Changes
  2. Why It Happens Anyway
  3. Why It Looks Worse With Age
  4. What Is Actually In Your Control
  5. The Trade-off, Framed Honestly
  6. FAQ
  7. Scientific references

What Actually Changes

The phenomenon is real and reasonably well characterised. It is the explanation that has been wrong.

The review found no evidence the drug preferentially strips facial fatSystematic review of 23 articles
“Ozempic Face” in Plastic Surgery: A Systematic Review — Aesthetic Surgery Journal Open Forum, 2025

Reviewing 23 articles, the authors describe volume loss across the temporal region, cheeks, tear trough, jawline, marionette lines and nasolabial folds. Their conclusion on cause is blunt: “Evidence to suggest that GLP-1 receptor agonists preferentially result in facial fat atrophy is lacking.” They propose the drugs merely accentuate age-related changes by leaving sagging skin over a thinner bed of fat.

Full review on PMC ↗

Bottom line: Read that conclusion again, because it contradicts almost everything written on this subject: the evidence that these drugs preferentially strip facial fat is lacking.

Why It Happens Anyway

If the drug is not selectively targeting your face, why does the face change so visibly?

Facial fat is fat. The face contains discrete fat compartments that give it volume and youthful contour. When you lose fat across the body, you lose it there too. This is not a side effect. It is fat loss, occurring in a place where a small absolute change is highly visible.

Skin does not keep pace. Fat volume falls faster than skin can retract, particularly when loss is rapid. What you see is not missing fat so much as skin that no longer has the same thing underneath it.

Neither mechanism is specific to GLP-1 medications. Both happen after bariatric surgery and after any substantial rapid weight loss.

Why It Looks Worse With Age

The review's proposed explanation is that these drugs accentuate age-related change rather than creating something new.

Skin elasticity declines with age, and the underlying facial skeleton changes too. At 30, skin retracts reasonably well over a smaller fat pad. At 55, it does not, so the same fat loss produces markedly more visible hollowing and laxity.

This is why two people can lose the same percentage of bodyweight on the same medication and get very different facial outcomes. The variable is mostly not the drug.

What Is Actually In Your Control

Very little, honestly — and being clear about that is more useful than selling a cream.

  • Rate of loss. Slower loss gives skin more time to adapt. Dose and pace are things a prescriber can adjust if this matters enough to you.
  • Protein intake. Not because it protects facial fat — it does not — but because collagen and skin structure are protein, and total intake commonly falls. See our protein guide.
  • Resistance training. Same caveat: it will not change your face. It changes what proportion of the weight you lose is fat rather than lean tissue, which is the outcome that matters more.

What will not help: facial exercises, creams marketed at this specifically, or supplements sold on the promise of preserving facial volume. There is no evidence base for any of it in this context.

Protein and resistance training named as the two prioritiesJoint clinical advisory
ACLM, ASN, OMA & The Obesity Society — American Journal of Clinical Nutrition, 2025

A joint advisory from four major U.S. nutrition and obesity societies sets a protein target of 1.2–1.6 g/kg body weight per day (or about 1.5 g/kg of lean body mass) during active weight loss, distributed at roughly 25–30 g per meal, and recommends structured resistance training alongside pharmacotherapy.

Read the advisory ↗

The Trade-off, Framed Honestly

This is a genuine cost and dismissing it is condescending. People care how they look, and a gaunt face is a real thing to weigh.

But weigh it against what it is: a visible consequence of losing a substantial amount of fat. The same loss that changed your face changed your cardiometabolic risk, and the trial extension data shows those improvements reverse if you stop:

Weight and cardiometabolic gains reversed after withdrawalRCT extension
Wilding JPH, et al. (STEP-1 extension) — Diabetes, Obesity and Metabolism, 2022

Following the original STEP-1 population after semaglutide was stopped, participants regained weight and the cardiometabolic improvements accrued during treatment reversed toward baseline.

Full study on PMC ↗

Important: Cosmetic procedures for facial volume are a legitimate option and one that plastic surgeons discuss with patients — but that is a conversation with a qualified clinician, not something to decide from a website. Do not stop a working medication over facial appearance without discussing it with your prescriber first.

GLP-1 Full Guide
The book

GLP-1 Full Guide

Everything on this page, and the other 39 articles, in one 151-page book — plus a 30-day protocol, four weeks of meal plans and the tracker pages, none of which are on the site.

19 peer-reviewed references, cited by PMID and DOI. Where two studies disagree, both are shown.

See the book →

FAQ

Does Ozempic cause facial aging?

A 2025 systematic review of 23 articles concluded that evidence the drugs preferentially cause facial fat atrophy is lacking. The changes are real, but they appear to be the effect of rapid weight loss rather than a drug-specific mechanism.

Which parts of the face change?

The review describes volume loss across the temporal region, cheeks, tear trough, jawline, marionette lines and nasolabial folds.

Can I prevent Ozempic face?

Only partly. A slower rate of weight loss gives skin more time to adapt, and adequate protein supports skin structure. Facial exercises, creams and supplements marketed for this have no evidence base.

Why does it look worse on some people?

Skin elasticity declines with age and the facial skeleton changes. The same fat loss produces far more visible hollowing at 55 than at 30 — the variable is mostly not the drug.

Will my face recover if I stop the medication?

Regaining weight would restore some facial volume, but the trial extension data shows weight regain and reversal of cardiometabolic improvements come together. That is a conversation for your prescriber, not a decision to make alone.

Scientific References

  1. “Ozempic Face” in Plastic Surgery: A Systematic Review of the Literature on GLP-1 Receptor Agonist Mediated Weight Loss and Analysis of Public Perceptions. Aesthetic Surgery Journal Open Forum, 2025. Full text on PMC.
  2. Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism, 2022. Full text on PMC.
  3. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. American Journal of Clinical Nutrition, 2025. Read the advisory.

Medical Disclaimer

This article is educational and not medical advice, and does not recommend, endorse, or provide dosing guidance for any prescription medication. GLP-1 medications require a prescription and medical supervision. Talk to a qualified clinician before starting, stopping, or changing any medication.

The Iron Verdict

Get the evidence, not the hype

Free, independent breakdowns of GLP-1 research, supplement evidence and product picks — straight to your inbox. No spam, no paid rankings.

Free forever. Unsubscribe anytime. No spam, no paid rankings.